.Merck beats earnings expectations, raises purchases overview on sturdy need for leading drugs like Keytruda CNBCMerck & Co. (MRK US) Beats Profit Projections as Keytruda Sales Rise BloombergMerck Supply: Pharma Titan Posts Powerful Results, But Overview Tumbles Short Capitalist's Organization DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck defeats income and also sales expectations among Keytruda asset, yet delivers blended full-year overview MarketWatch.